

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 8.43731016 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 8.43731016 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 8.43731016 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 8.43731016 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 8.43731016 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 8.43731016 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 7.12342486 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 6.08297665 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.03594644 |
| 10 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.69562766 |
| 11 | microglial cell activation (GO:0001774) | 5.54497555 |
| 12 | positive regulation of interferon-alpha production (GO:0032727) | 5.49687357 |
| 13 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.48422811 |
| 14 | response to host immune response (GO:0052572) | 5.48422811 |
| 15 | regulation of interferon-alpha production (GO:0032647) | 5.21127817 |
| 16 | detection of other organism (GO:0098543) | 5.18273327 |
| 17 | response to host (GO:0075136) | 4.98110092 |
| 18 | response to host defenses (GO:0052200) | 4.98110092 |
| 19 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.98110092 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 4.96022548 |
| 21 | detection of bacterium (GO:0016045) | 4.78066492 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 4.55876713 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.48280087 |
| 24 | detection of external biotic stimulus (GO:0098581) | 4.42637950 |
| 25 | macrophage activation (GO:0042116) | 4.36236056 |
| 26 | response to peptidoglycan (GO:0032494) | 4.31381325 |
| 27 | respiratory burst (GO:0045730) | 4.23591802 |
| 28 | positive regulation of antigen processing and presentation (GO:0002579) | 4.07610408 |
| 29 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.05936377 |
| 30 | detection of biotic stimulus (GO:0009595) | 4.00026931 |
| 31 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.94029053 |
| 32 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.90946286 |
| 33 | myeloid cell activation involved in immune response (GO:0002275) | 3.85727707 |
| 34 | I-kappaB phosphorylation (GO:0007252) | 3.81653072 |
| 35 | positive regulation of interferon-beta production (GO:0032728) | 3.80606905 |
| 36 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.75770819 |
| 37 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.75354826 |
| 38 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.75236026 |
| 39 | negative regulation of T cell mediated immunity (GO:0002710) | 3.74104573 |
| 40 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.66012491 |
| 41 | leukocyte aggregation (GO:0070486) | 3.65075314 |
| 42 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.59965550 |
| 43 | regulation of tolerance induction (GO:0002643) | 3.59859458 |
| 44 | regulation of T cell tolerance induction (GO:0002664) | 3.58374137 |
| 45 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.49980142 |
| 46 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.49980142 |
| 47 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.48754524 |
| 48 | granulocyte activation (GO:0036230) | 3.48053705 |
| 49 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.44497377 |
| 50 | pinocytosis (GO:0006907) | 3.42059846 |
| 51 | neutrophil activation (GO:0042119) | 3.41700476 |
| 52 | positive regulation of mast cell activation (GO:0033005) | 3.41224050 |
| 53 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.40778983 |
| 54 | regulation of mononuclear cell migration (GO:0071675) | 3.39579884 |
| 55 | regulation of antigen processing and presentation (GO:0002577) | 3.38467224 |
| 56 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.35006125 |
| 57 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.34611581 |
| 58 | regulation of cholesterol storage (GO:0010885) | 3.31566609 |
| 59 | regulation of mast cell degranulation (GO:0043304) | 3.30835916 |
| 60 | B cell receptor signaling pathway (GO:0050853) | 3.25151655 |
| 61 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.24776173 |
| 62 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.24388672 |
| 63 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.24286932 |
| 64 | B cell mediated immunity (GO:0019724) | 3.18579840 |
| 65 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.16169225 |
| 66 | positive thymic T cell selection (GO:0045059) | 3.15085538 |
| 67 | positive regulation of B cell differentiation (GO:0045579) | 3.14817848 |
| 68 | T cell migration (GO:0072678) | 3.13975227 |
| 69 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.10909432 |
| 70 | negative regulation of cell killing (GO:0031342) | 3.10909432 |
| 71 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.10864949 |
| 72 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.10377216 |
| 73 | response to muramyl dipeptide (GO:0032495) | 3.10084652 |
| 74 | regulation of mast cell activation (GO:0033003) | 3.08207935 |
| 75 | neutrophil mediated immunity (GO:0002446) | 3.07731075 |
| 76 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.06871906 |
| 77 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.06138772 |
| 78 | regulation of B cell differentiation (GO:0045577) | 3.04154737 |
| 79 | positive regulation of leukocyte degranulation (GO:0043302) | 3.03535607 |
| 80 | regulation of leukocyte degranulation (GO:0043300) | 3.03290141 |
| 81 | detection of molecule of bacterial origin (GO:0032490) | 3.02810618 |
| 82 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.02728862 |
| 83 | positive regulation of tolerance induction (GO:0002645) | 3.02655571 |
| 84 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.02046001 |
| 85 | apoptotic cell clearance (GO:0043277) | 3.01975152 |
| 86 | T-helper 1 type immune response (GO:0042088) | 3.01463883 |
| 87 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.00952169 |
| 88 | low-density lipoprotein particle clearance (GO:0034383) | 3.00900687 |
| 89 | negative regulation of interleukin-17 production (GO:0032700) | 3.00604730 |
| 90 | negative thymic T cell selection (GO:0045060) | 3.00233619 |
| 91 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.98780203 |
| 92 | mannose metabolic process (GO:0006013) | 2.98724804 |
| 93 | regulation of regulated secretory pathway (GO:1903305) | 2.98646748 |
| 94 | cellular extravasation (GO:0045123) | 2.98564572 |
| 95 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.98238988 |
| 96 | myeloid leukocyte mediated immunity (GO:0002444) | 2.97648343 |
| 97 | positive regulation of type 2 immune response (GO:0002830) | 2.94332064 |
| 98 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.93955949 |
| 99 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.93077428 |
| 100 | positive regulation of mast cell degranulation (GO:0043306) | 2.92954369 |
| 101 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.92954369 |
| 102 | negative regulation of mast cell activation (GO:0033004) | 2.91480420 |
| 103 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.90646678 |
| 104 | activated T cell proliferation (GO:0050798) | 2.90030013 |
| 105 | negative T cell selection (GO:0043383) | 2.89750424 |
| 106 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.89135444 |
| 107 | T cell selection (GO:0045058) | 2.87169537 |
| 108 | dendritic cell migration (GO:0036336) | 2.85739401 |
| 109 | myeloid leukocyte activation (GO:0002274) | 2.84962493 |
| 110 | germinal center formation (GO:0002467) | 2.84442050 |
| 111 | regulation of interferon-beta production (GO:0032648) | 2.84353620 |
| 112 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.83703767 |
| 113 | dendritic cell chemotaxis (GO:0002407) | 2.82947984 |
| 114 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.81342624 |
| 115 | natural killer cell mediated immunity (GO:0002228) | 2.81342624 |
| 116 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.76849961 |
| 117 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.76069156 |
| 118 | type I interferon signaling pathway (GO:0060337) | 2.75478612 |
| 119 | cellular response to type I interferon (GO:0071357) | 2.75478612 |
| 120 | response to type I interferon (GO:0034340) | 2.74509625 |
| 121 | negative regulation of interleukin-6 production (GO:0032715) | 2.73108763 |
| 122 | reactive oxygen species biosynthetic process (GO:1903409) | 2.72538339 |
| 123 | negative regulation of interleukin-12 production (GO:0032695) | 2.69970105 |
| 124 | positive regulation of chemokine production (GO:0032722) | 2.69401663 |
| 125 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.66766725 |
| 126 | hyaluronan catabolic process (GO:0030214) | 2.65370516 |
| 127 | negative regulation of granulocyte differentiation (GO:0030853) | 2.63458610 |
| 128 | neutrophil chemotaxis (GO:0030593) | 2.61665527 |
| 129 | glycosphingolipid catabolic process (GO:0046479) | 2.61663798 |
| 130 | superoxide anion generation (GO:0042554) | 2.57876308 |
| 131 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.56868120 |
| 132 | positive regulation of macrophage cytokine production (GO:0060907) | 2.56645560 |
| 133 | phagosome maturation (GO:0090382) | 2.56404799 |
| 134 | leukocyte mediated cytotoxicity (GO:0001909) | 2.55934962 |
| 135 | lymphocyte chemotaxis (GO:0048247) | 2.55184765 |
| 136 | neutrophil migration (GO:1990266) | 2.53872817 |
| 137 | defense response to protozoan (GO:0042832) | 2.53487696 |
| 138 | response to interferon-alpha (GO:0035455) | 2.53308972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.86101668 |
| 2 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.55371615 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.19515480 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.80529876 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.49779755 |
| 6 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.96672980 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.96476750 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.23062787 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.17421868 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.04646538 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.01546417 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.82352176 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.80605281 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.63560596 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.62049034 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.52349358 |
| 17 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.43654907 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.37248150 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.33839995 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.22361899 |
| 21 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.19840421 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.07756425 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.03585767 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.03582416 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.99720813 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.94438315 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.92673750 |
| 28 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.84362336 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.83997029 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.83684957 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82440854 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.82397114 |
| 33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.79138149 |
| 34 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.74454666 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.74293121 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.73478150 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.70279479 |
| 38 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.64096390 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.62333706 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61815903 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58430421 |
| 42 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.58105319 |
| 43 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.57047129 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.56049885 |
| 45 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55932312 |
| 46 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55263068 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 1.53156098 |
| 48 | MYB_26560356_Chip-Seq_TH2_Human | 1.46889445 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46852331 |
| 50 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44898521 |
| 51 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.41780516 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41685441 |
| 53 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31445936 |
| 54 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30708450 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30124742 |
| 56 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30023621 |
| 57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26569634 |
| 58 | MYB_26560356_Chip-Seq_TH1_Human | 1.24651354 |
| 59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19456252 |
| 60 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17386735 |
| 61 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.17067428 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16353418 |
| 63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15640938 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15316658 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13940966 |
| 66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.12764781 |
| 67 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12207506 |
| 68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11887970 |
| 69 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11235889 |
| 70 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10801153 |
| 71 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10203867 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09218861 |
| 73 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08082162 |
| 74 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06284832 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06066515 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06020055 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05776704 |
| 78 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05027538 |
| 79 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04567526 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02250161 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01056061 |
| 82 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00233200 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98127546 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97572757 |
| 85 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95288616 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94341605 |
| 87 | MYC_22102868_ChIP-Seq_BL_Human | 0.93919405 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93832458 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91967508 |
| 90 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90388347 |
| 91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89926154 |
| 92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.89899432 |
| 93 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.89661534 |
| 94 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89089336 |
| 95 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88643218 |
| 96 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.88530826 |
| 97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86096435 |
| 98 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85907951 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82855608 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82825209 |
| 101 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82279786 |
| 102 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80436108 |
| 103 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80336413 |
| 104 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80103199 |
| 105 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79782669 |
| 106 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.79537059 |
| 107 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.78980761 |
| 108 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.78622317 |
| 109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.78555387 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77771203 |
| 111 | MAF_26560356_Chip-Seq_TH2_Human | 0.76968520 |
| 112 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.76022615 |
| 113 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.75471734 |
| 114 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.74932513 |
| 115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74913729 |
| 116 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.74311641 |
| 117 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.71297829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.90643105 |
| 2 | MP0003303_peritoneal_inflammation | 3.96223829 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.87045619 |
| 4 | MP0006082_CNS_inflammation | 3.47050185 |
| 5 | MP0003172_abnormal_lysosome_physiology | 3.43540868 |
| 6 | MP0003436_decreased_susceptibility_to | 3.43362666 |
| 7 | MP0009840_abnormal_foam_cell | 3.20820551 |
| 8 | MP0002419_abnormal_innate_immunity | 3.05127356 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.90240231 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.63251419 |
| 11 | MP0005387_immune_system_phenotype | 2.43161906 |
| 12 | MP0001790_abnormal_immune_system | 2.43161906 |
| 13 | MP0009785_altered_susceptibility_to | 2.41731866 |
| 14 | MP0005025_abnormal_response_to | 2.39700041 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.35738033 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.34968380 |
| 17 | MP0004510_myositis | 2.33547168 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.26453782 |
| 19 | MP0003690_abnormal_glial_cell | 2.20089770 |
| 20 | MP0000604_amyloidosis | 2.17616548 |
| 21 | MP0000569_abnormal_digit_pigmentation | 2.16464241 |
| 22 | MP0001800_abnormal_humoral_immune | 2.13925012 |
| 23 | MP0003724_increased_susceptibility_to | 2.12929703 |
| 24 | MP0002723_abnormal_immune_serum | 2.09777486 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.06093529 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.99951882 |
| 27 | MP0000685_abnormal_immune_system | 1.92465775 |
| 28 | MP0008260_abnormal_autophagy | 1.92069899 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.88828392 |
| 30 | MP0001819_abnormal_immune_cell | 1.86974164 |
| 31 | MP0005671_abnormal_response_to | 1.86456372 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.84715771 |
| 33 | MP0003075_altered_response_to | 1.77097304 |
| 34 | MP0004947_skin_inflammation | 1.70155979 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.69287071 |
| 36 | MP0008469_abnormal_protein_level | 1.69040091 |
| 37 | MP0005257_abnormal_intraocular_pressure | 1.64876772 |
| 38 | MP0002405_respiratory_system_inflammati | 1.63206021 |
| 39 | MP0003448_altered_tumor_morphology | 1.63050839 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.62993999 |
| 41 | MP0000343_altered_response_to | 1.60707275 |
| 42 | MP0005451_abnormal_body_composition | 1.55533474 |
| 43 | MP0005310_abnormal_salivary_gland | 1.51814076 |
| 44 | MP0002132_abnormal_respiratory_system | 1.48132320 |
| 45 | MP0009278_abnormal_bone_marrow | 1.46985707 |
| 46 | MP0001853_heart_inflammation | 1.41684103 |
| 47 | MP0010307_abnormal_tumor_latency | 1.40290255 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.40141501 |
| 49 | MP0009764_decreased_sensitivity_to | 1.39349913 |
| 50 | MP0003866_abnormal_defecation | 1.35279183 |
| 51 | MP0000716_abnormal_immune_system | 1.33842868 |
| 52 | MP0005166_decreased_susceptibility_to | 1.33829065 |
| 53 | MP0005167_abnormal_blood-brain_barrier | 1.31800809 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.27772963 |
| 55 | MP0005083_abnormal_biliary_tract | 1.24754626 |
| 56 | MP0001851_eye_inflammation | 1.23391458 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.19856241 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.17904660 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.15600772 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.15297562 |
| 61 | MP0002398_abnormal_bone_marrow | 1.15077830 |
| 62 | MP0003705_abnormal_hypodermis_morpholog | 1.13922907 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.13683660 |
| 64 | MP0008004_abnormal_stomach_pH | 1.10514264 |
| 65 | MP0005174_abnormal_tail_pigmentation | 1.08819510 |
| 66 | MP0002429_abnormal_blood_cell | 1.07634463 |
| 67 | MP0002166_altered_tumor_susceptibility | 1.06551850 |
| 68 | MP0004381_abnormal_hair_follicle | 1.06439255 |
| 69 | MP0000858_altered_metastatic_potential | 1.05680831 |
| 70 | MP0002090_abnormal_vision | 1.04466645 |
| 71 | MP0002722_abnormal_immune_system | 1.02840577 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 1.02473179 |
| 73 | MP0004782_abnormal_surfactant_physiolog | 0.99775603 |
| 74 | MP0002396_abnormal_hematopoietic_system | 0.98788929 |
| 75 | MP0001545_abnormal_hematopoietic_system | 0.97465497 |
| 76 | MP0005397_hematopoietic_system_phenotyp | 0.97465497 |
| 77 | MP0000609_abnormal_liver_physiology | 0.95026051 |
| 78 | MP0009763_increased_sensitivity_to | 0.94475010 |
| 79 | MP0008438_abnormal_cutaneous_collagen | 0.93568458 |
| 80 | MP0002006_tumorigenesis | 0.91720838 |
| 81 | MP0001958_emphysema | 0.90744049 |
| 82 | MP0005164_abnormal_response_to | 0.89884820 |
| 83 | MP0005076_abnormal_cell_differentiation | 0.89514540 |
| 84 | MP0002933_joint_inflammation | 0.89140597 |
| 85 | MP0005390_skeleton_phenotype | 0.88992198 |
| 86 | MP0002009_preneoplasia | 0.87331447 |
| 87 | MP0002254_reproductive_system_inflammat | 0.86723992 |
| 88 | MP0001663_abnormal_digestive_system | 0.86565648 |
| 89 | MP0010329_abnormal_lipoprotein_level | 0.86045430 |
| 90 | MP0000249_abnormal_blood_vessel | 0.85919746 |
| 91 | MP0003828_pulmonary_edema | 0.85026843 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.83679336 |
| 93 | MP0005360_urolithiasis | 0.83011417 |
| 94 | MP0002139_abnormal_hepatobiliary_system | 0.81478291 |
| 95 | MP0004130_abnormal_muscle_cell | 0.78333278 |
| 96 | MP0004858_abnormal_nervous_system | 0.75235491 |
| 97 | MP0003806_abnormal_nucleotide_metabolis | 0.74931485 |
| 98 | MP0000920_abnormal_myelination | 0.74664109 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.72816877 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 0.71001436 |
| 101 | MP0000598_abnormal_liver_morphology | 0.70330533 |
| 102 | MP0000371_diluted_coat_color | 0.70227142 |
| 103 | MP0000767_abnormal_smooth_muscle | 0.68632292 |
| 104 | MP0004808_abnormal_hematopoietic_stem | 0.68495453 |
| 105 | MP0003795_abnormal_bone_structure | 0.68137135 |
| 106 | MP0006054_spinal_hemorrhage | 0.67805322 |
| 107 | MP0004883_abnormal_blood_vessel | 0.67644981 |
| 108 | MP0003091_abnormal_cell_migration | 0.67554346 |
| 109 | MP0001873_stomach_inflammation | 0.65974814 |
| 110 | MP0005075_abnormal_melanosome_morpholog | 0.65756975 |
| 111 | MP0009765_abnormal_xenobiotic_induced | 0.64248727 |
| 112 | MP0002138_abnormal_hepatobiliary_system | 0.63592768 |
| 113 | MP0003195_calcinosis | 0.63135067 |
| 114 | MP0008875_abnormal_xenobiotic_pharmacok | 0.62940084 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62938386 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.62758501 |
| 117 | MP0004185_abnormal_adipocyte_glucose | 0.62432972 |
| 118 | MP0000490_abnormal_crypts_of | 0.61066909 |
| 119 | MP0008874_decreased_physiological_sensi | 0.60335402 |
| 120 | MP0003045_fibrosis | 0.58938120 |
| 121 | MP0001986_abnormal_taste_sensitivity | 0.58520089 |
| 122 | MP0003221_abnormal_cardiomyocyte_apopto | 0.57250198 |
| 123 | MP0003329_amyloid_beta_deposits | 0.55946593 |
| 124 | MP0003453_abnormal_keratinocyte_physiol | 0.53767187 |
| 125 | MP0002133_abnormal_respiratory_system | 0.51656700 |
| 126 | MP0005388_respiratory_system_phenotype | 0.51656700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 6.66913008 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.26120932 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 5.77456805 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 5.68830808 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.64311115 |
| 6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.54892703 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.51067963 |
| 8 | Eczematoid dermatitis (HP:0000976) | 5.50598393 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 5.07325765 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.07325765 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.07325765 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.88954823 |
| 13 | Dysostosis multiplex (HP:0000943) | 4.80664768 |
| 14 | Glomerulonephritis (HP:0000099) | 4.35287581 |
| 15 | Disinhibition (HP:0000734) | 4.20256624 |
| 16 | Axonal loss (HP:0003447) | 4.05794198 |
| 17 | Mucopolysacchariduria (HP:0008155) | 4.00960766 |
| 18 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.00960766 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 3.82400331 |
| 20 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.81681139 |
| 21 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.81681139 |
| 22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.81681139 |
| 23 | Loss of speech (HP:0002371) | 3.68874181 |
| 24 | Complement deficiency (HP:0004431) | 3.58612648 |
| 25 | Keratoconjunctivitis sicca (HP:0001097) | 3.57082790 |
| 26 | Recurrent skin infections (HP:0001581) | 3.40587398 |
| 27 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.40237439 |
| 28 | Encephalitis (HP:0002383) | 3.37644858 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 3.37159210 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.34898850 |
| 31 | Myocardial infarction (HP:0001658) | 3.33395143 |
| 32 | Mediastinal lymphadenopathy (HP:0100721) | 3.32389358 |
| 33 | Gingivitis (HP:0000230) | 3.32097800 |
| 34 | Keratoconjunctivitis (HP:0001096) | 3.27420594 |
| 35 | Hemoptysis (HP:0002105) | 3.20382882 |
| 36 | Obstructive lung disease (HP:0006536) | 3.19872027 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 3.19872027 |
| 38 | Abnormality of complement system (HP:0005339) | 3.18230159 |
| 39 | Myositis (HP:0100614) | 3.16080115 |
| 40 | T lymphocytopenia (HP:0005403) | 3.09863290 |
| 41 | Chest pain (HP:0100749) | 2.99981266 |
| 42 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.97619083 |
| 43 | Abnormality of T cell number (HP:0011839) | 2.93889417 |
| 44 | Orchitis (HP:0100796) | 2.93373704 |
| 45 | Prolonged bleeding time (HP:0003010) | 2.93130801 |
| 46 | Increased IgE level (HP:0003212) | 2.92158066 |
| 47 | Upper motor neuron abnormality (HP:0002127) | 2.87998266 |
| 48 | Agnosia (HP:0010524) | 2.85533127 |
| 49 | Hepatosplenomegaly (HP:0001433) | 2.83207636 |
| 50 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.80415954 |
| 51 | Nephritis (HP:0000123) | 2.79918021 |
| 52 | Hematochezia (HP:0002573) | 2.76936700 |
| 53 | Recurrent fungal infections (HP:0002841) | 2.75823560 |
| 54 | Episodic fever (HP:0001954) | 2.71262641 |
| 55 | Epistaxis (HP:0000421) | 2.66856282 |
| 56 | Pulmonary embolism (HP:0002204) | 2.59587305 |
| 57 | J-shaped sella turcica (HP:0002680) | 2.57923677 |
| 58 | Neuronal loss in central nervous system (HP:0002529) | 2.57699640 |
| 59 | Interstitial pulmonary disease (HP:0006530) | 2.56171252 |
| 60 | Peritonitis (HP:0002586) | 2.51669838 |
| 61 | Periodontitis (HP:0000704) | 2.49970186 |
| 62 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.49673278 |
| 63 | Retinal atrophy (HP:0001105) | 2.48407712 |
| 64 | Basal ganglia calcification (HP:0002135) | 2.47551155 |
| 65 | Joint hemorrhage (HP:0005261) | 2.47282178 |
| 66 | Purpura (HP:0000979) | 2.46945384 |
| 67 | Mutism (HP:0002300) | 2.45905163 |
| 68 | Cellulitis (HP:0100658) | 2.44716027 |
| 69 | Thoracic kyphosis (HP:0002942) | 2.44216870 |
| 70 | Optic neuritis (HP:0100653) | 2.43922004 |
| 71 | Retrobulbar optic neuritis (HP:0100654) | 2.43922004 |
| 72 | Pathologic fracture (HP:0002756) | 2.43736234 |
| 73 | Abnormality of the lumbar spine (HP:0100712) | 2.42580861 |
| 74 | Stomatitis (HP:0010280) | 2.42038346 |
| 75 | Recurrent viral infections (HP:0004429) | 2.41014953 |
| 76 | Petechiae (HP:0000967) | 2.40654129 |
| 77 | Gangrene (HP:0100758) | 2.40462710 |
| 78 | Anorexia (HP:0002039) | 2.39975823 |
| 79 | Spontaneous hematomas (HP:0007420) | 2.38532460 |
| 80 | Urticaria (HP:0001025) | 2.37951589 |
| 81 | Asymmetric septal hypertrophy (HP:0001670) | 2.37654853 |
| 82 | Thick nail (HP:0001805) | 2.36158847 |
| 83 | Peripheral demyelination (HP:0011096) | 2.35436953 |
| 84 | Abnormality of T cells (HP:0002843) | 2.35294757 |
| 85 | Pustule (HP:0200039) | 2.34449976 |
| 86 | Conjunctival telangiectasia (HP:0000524) | 2.32359458 |
| 87 | Vasculitis (HP:0002633) | 2.32164540 |
| 88 | Panhypogammaglobulinemia (HP:0003139) | 2.29478910 |
| 89 | Apathy (HP:0000741) | 2.25911898 |
| 90 | Global brain atrophy (HP:0002283) | 2.25491212 |
| 91 | Increased IgM level (HP:0003496) | 2.24601637 |
| 92 | Abnormality of the pleura (HP:0002103) | 2.24363826 |
| 93 | Diminished motivation (HP:0000745) | 2.24177762 |
| 94 | Increased CSF protein (HP:0002922) | 2.23992553 |
| 95 | Increased serum ferritin (HP:0003281) | 2.22629164 |
| 96 | Chronic otitis media (HP:0000389) | 2.20974434 |
| 97 | Prostate neoplasm (HP:0100787) | 2.19714890 |
| 98 | Colitis (HP:0002583) | 2.19328745 |
| 99 | Vertigo (HP:0002321) | 2.18084794 |
| 100 | Osteomyelitis (HP:0002754) | 2.17933766 |
| 101 | Amyloidosis (HP:0011034) | 2.16018533 |
| 102 | Inappropriate behavior (HP:0000719) | 2.14794408 |
| 103 | Polyneuropathy (HP:0001271) | 2.14659942 |
| 104 | Granulocytopenia (HP:0001913) | 2.12903472 |
| 105 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.12561492 |
| 106 | Malnutrition (HP:0004395) | 2.12098319 |
| 107 | Sepsis (HP:0100806) | 2.10158414 |
| 108 | Amaurosis fugax (HP:0100576) | 2.09562338 |
| 109 | Neurofibrillary tangles (HP:0002185) | 2.06549666 |
| 110 | Tetraparesis (HP:0002273) | 2.06131157 |
| 111 | Glomerulopathy (HP:0100820) | 2.04312829 |
| 112 | Gingival bleeding (HP:0000225) | 2.03363499 |
| 113 | Abnormality of the peritoneum (HP:0002585) | 2.03106386 |
| 114 | Bone pain (HP:0002653) | 2.02267384 |
| 115 | Abnormality of the endocardium (HP:0004306) | 2.02211508 |
| 116 | Hypercholesterolemia (HP:0003124) | 2.00901844 |
| 117 | Lymphopenia (HP:0001888) | 2.00513339 |
| 118 | Abnormality of iron homeostasis (HP:0011031) | 1.98838806 |
| 119 | Agammaglobulinemia (HP:0004432) | 1.98586842 |
| 120 | Hypergammaglobulinemia (HP:0010702) | 1.98446556 |
| 121 | Osteolytic defects of the hand bones (HP:0009699) | 1.97987378 |
| 122 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97987378 |
| 123 | Inflammation of the large intestine (HP:0002037) | 1.96431803 |
| 124 | Progressive visual loss (HP:0000529) | 1.94525818 |
| 125 | Supranuclear gaze palsy (HP:0000605) | 1.94262596 |
| 126 | Skin ulcer (HP:0200042) | 1.94081844 |
| 127 | Progressive neurologic deterioration (HP:0002344) | 1.93646841 |
| 128 | Personality changes (HP:0000751) | 1.93253953 |
| 129 | Arterial thrombosis (HP:0004420) | 1.92695162 |
| 130 | Esophageal varix (HP:0002040) | 1.92593270 |
| 131 | Hypochromic anemia (HP:0001931) | 1.91548935 |
| 132 | Recurrent cutaneous fungal infections (HP:0011370) | 1.91383327 |
| 133 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.91383327 |
| 134 | Meningitis (HP:0001287) | 1.90630616 |
| 135 | Thrombocytosis (HP:0001894) | 1.89477226 |
| 136 | Cerebral aneurysm (HP:0004944) | 1.89394172 |
| 137 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.88590123 |
| 138 | Pulmonary infiltrates (HP:0002113) | 1.88571208 |
| 139 | Eosinophilia (HP:0001880) | 1.88423983 |
| 140 | Acne (HP:0001061) | 1.88212891 |
| 141 | Viral hepatitis (HP:0006562) | 1.84636303 |
| 142 | Cheilitis (HP:0100825) | 1.84174391 |
| 143 | Leukocytosis (HP:0001974) | 1.84068352 |
| 144 | Abnormality of the thoracic spine (HP:0100711) | 1.83396507 |
| 145 | Gastrointestinal inflammation (HP:0004386) | 1.80952377 |
| 146 | Recurrent pneumonia (HP:0006532) | 1.78077411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.62050513 |
| 2 | RIPK4 | 3.53442800 |
| 3 | TYK2 | 3.49261924 |
| 4 | TGFBR2 | 3.27487628 |
| 5 | ERN1 | 3.24867352 |
| 6 | TBK1 | 3.20523082 |
| 7 | KIT | 3.12640144 |
| 8 | PRPF4B | 2.92041741 |
| 9 | IRAK4 | 2.74826719 |
| 10 | MAP4K1 | 2.71386461 |
| 11 | MAP3K14 | 2.57782055 |
| 12 | IRAK3 | 2.46155058 |
| 13 | CSF1R | 2.34328217 |
| 14 | JAK1 | 2.05246235 |
| 15 | CAMK1D | 1.93612236 |
| 16 | IKBKE | 1.89237865 |
| 17 | TAOK3 | 1.86898336 |
| 18 | CSK | 1.76523540 |
| 19 | TRIB3 | 1.74730599 |
| 20 | FES | 1.70590837 |
| 21 | TNK2 | 1.70585845 |
| 22 | EPHB1 | 1.67049342 |
| 23 | IKBKB | 1.60450150 |
| 24 | ZAP70 | 1.56392514 |
| 25 | FGR | 1.53791981 |
| 26 | HCK | 1.52754370 |
| 27 | JAK3 | 1.48690922 |
| 28 | MAP3K13 | 1.48561778 |
| 29 | NEK9 | 1.43500424 |
| 30 | TAOK1 | 1.43289201 |
| 31 | SYK | 1.39641033 |
| 32 | MAP2K3 | 1.38816422 |
| 33 | CAMK1G | 1.36380156 |
| 34 | JAK2 | 1.35201652 |
| 35 | PKN2 | 1.32080569 |
| 36 | RIPK1 | 1.31821088 |
| 37 | STK10 | 1.30578730 |
| 38 | BMPR2 | 1.30088444 |
| 39 | PBK | 1.23442033 |
| 40 | SCYL2 | 1.20264727 |
| 41 | MATK | 1.18470366 |
| 42 | LYN | 1.17265342 |
| 43 | YES1 | 1.13951683 |
| 44 | TTN | 1.13637575 |
| 45 | FGFR4 | 1.12348697 |
| 46 | SIK3 | 1.11782100 |
| 47 | PTK6 | 1.10365377 |
| 48 | GRK7 | 1.09274607 |
| 49 | LCK | 1.09228381 |
| 50 | BTK | 1.06453960 |
| 51 | PAK4 | 1.01174840 |
| 52 | IRAK1 | 0.93573841 |
| 53 | IRAK2 | 0.91460105 |
| 54 | CAMKK2 | 0.90900645 |
| 55 | SIK2 | 0.90401417 |
| 56 | ITK | 0.89262489 |
| 57 | TXK | 0.88892849 |
| 58 | EGFR | 0.88813436 |
| 59 | FGFR3 | 0.88173189 |
| 60 | MARK2 | 0.86757342 |
| 61 | MAP3K3 | 0.86525552 |
| 62 | LRRK2 | 0.84829871 |
| 63 | RPS6KA4 | 0.83850122 |
| 64 | MARK3 | 0.83786895 |
| 65 | ABL2 | 0.81203662 |
| 66 | MAPK7 | 0.80272483 |
| 67 | CDC42BPA | 0.80163910 |
| 68 | TAOK2 | 0.79935215 |
| 69 | CDK6 | 0.79089811 |
| 70 | CHUK | 0.79088063 |
| 71 | GRK6 | 0.78481900 |
| 72 | CLK1 | 0.77609454 |
| 73 | BMX | 0.76264943 |
| 74 | CAMKK1 | 0.73763679 |
| 75 | MAPK12 | 0.70799954 |
| 76 | PIM2 | 0.70443798 |
| 77 | ABL1 | 0.67128467 |
| 78 | MOS | 0.66879714 |
| 79 | TEC | 0.65007595 |
| 80 | KSR2 | 0.63712710 |
| 81 | PRKCD | 0.62099543 |
| 82 | NME2 | 0.61602711 |
| 83 | PIM1 | 0.61041867 |
| 84 | CDK19 | 0.60830317 |
| 85 | CDK12 | 0.58851672 |
| 86 | PDPK1 | 0.55507164 |
| 87 | MAP3K6 | 0.55121419 |
| 88 | MAP3K11 | 0.54505274 |
| 89 | FYN | 0.53943542 |
| 90 | PRKD2 | 0.53924475 |
| 91 | MAP3K10 | 0.53798580 |
| 92 | MAP3K7 | 0.51503390 |
| 93 | TESK2 | 0.50464357 |
| 94 | PDK1 | 0.49203760 |
| 95 | NLK | 0.49128884 |
| 96 | TRPM7 | 0.46853334 |
| 97 | HIPK2 | 0.45625991 |
| 98 | SGK2 | 0.44785429 |
| 99 | DYRK1B | 0.44524206 |
| 100 | KSR1 | 0.42912185 |
| 101 | DAPK2 | 0.41547053 |
| 102 | MAP3K1 | 0.41378005 |
| 103 | RPS6KL1 | 0.40818050 |
| 104 | RPS6KC1 | 0.40818050 |
| 105 | STK4 | 0.40387756 |
| 106 | EPHA3 | 0.40180789 |
| 107 | STK11 | 0.38936714 |
| 108 | PIK3CG | 0.38489744 |
| 109 | PRKCH | 0.37021549 |
| 110 | GSK3A | 0.36881514 |
| 111 | IGF1R | 0.36455291 |
| 112 | MAP3K5 | 0.35079217 |
| 113 | STK3 | 0.35071757 |
| 114 | RET | 0.34526937 |
| 115 | RPS6KA6 | 0.34143862 |
| 116 | ALK | 0.33796242 |
| 117 | RAF1 | 0.32011558 |
| 118 | MAP2K4 | 0.31674420 |
| 119 | MAPKAPK2 | 0.31505169 |
| 120 | PTK2B | 0.31303768 |
| 121 | PDGFRB | 0.30816202 |
| 122 | SIK1 | 0.30726869 |
| 123 | MAP3K2 | 0.30707628 |
| 124 | SRC | 0.28170506 |
| 125 | MAPK4 | 0.28162534 |
| 126 | PRKCQ | 0.27701603 |
| 127 | SGK3 | 0.27407663 |
| 128 | MAPK15 | 0.26586436 |
| 129 | RPS6KA2 | 0.26098050 |
| 130 | MAP3K9 | 0.26081930 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.36257260 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.98212528 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 3.63191848 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.04263103 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.91326512 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.65308926 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.52684264 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.43240149 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.29442514 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 2.29329730 |
| 11 | Phagosome_Homo sapiens_hsa04145 | 2.03747015 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.93915009 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.91876248 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.91717167 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.79080763 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.74561888 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.74514676 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.66598574 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.62657503 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.61512585 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.61415541 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.56450072 |
| 23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.55183808 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54498479 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.46846484 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42859431 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.41668059 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.35667125 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.33248005 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.30866057 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24295444 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.23790636 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.22035333 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18909842 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17418104 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13972080 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.10430283 |
| 38 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.05190658 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.04315046 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.01651878 |
| 41 | Prion diseases_Homo sapiens_hsa05020 | 1.01036303 |
| 42 | Asthma_Homo sapiens_hsa05310 | 0.98068315 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.97794395 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96788705 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95201809 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93127852 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91961438 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.91195178 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 0.90049001 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.87422854 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.87322131 |
| 52 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.86070543 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84402399 |
| 54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84292697 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 0.84205860 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81013817 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.79680666 |
| 58 | Allograft rejection_Homo sapiens_hsa05330 | 0.79506944 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78916030 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77963816 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77039991 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75620243 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74939209 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69227578 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67480148 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.67232017 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62924624 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.62906003 |
| 69 | Viral myocarditis_Homo sapiens_hsa05416 | 0.61041128 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60246568 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60029200 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.58801485 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58218186 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.56259866 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55373872 |
| 76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54760927 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54257622 |
| 78 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.54157422 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50782427 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50153017 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48894791 |
| 82 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48476277 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48437532 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | 0.47802224 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47773268 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47154583 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46957613 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46907327 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46797332 |
| 90 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.43368646 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43272710 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43149566 |
| 93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43087092 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41805493 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41732883 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40119148 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.39410098 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39374966 |
| 99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39180625 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38578708 |
| 101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36772466 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36154454 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35903540 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35315487 |
| 105 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34623203 |
| 106 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.33873793 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33233494 |
| 108 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.33080514 |
| 109 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33079074 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.29762402 |
| 111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29485928 |
| 112 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.29404158 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28970152 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.28829521 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27502178 |
| 116 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.22524181 |
| 117 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.21386663 |
| 118 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.21267047 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20909080 |
| 120 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.19941836 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.19850425 |
| 122 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.19384635 |

